At this stage, the TME is typically immunosuppressive, e.g. enriched with regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), etc., and the infiltrating tumor-specific CD4 and CD8 T cells are often dysfunctional (Figure 2C). Here, CD4 is linked to neoplasm.